Doxazosin
"Discount generic doxazosin uk, gastritis and gastroparesis diet."
By: Paul Reynolds, PharmD, BCPS
- Critical Care Pharmacy Specialist, University of Colorado Hospital
- Clinical Assistant Professor, Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado
http://www.ucdenver.edu/academics/colleges/pharmacy/Departments/ClinicalPharmacy/DOCPFaculty/Q-Z/Pages/Paul-Reynolds,-PharmD.aspx
Other possible manifes tations of neonatal gonococcal infection include scalp abscess (which can be associ ated with fetal scalp monitoring) and disseminated disease with bacteremia symptoms of gastritis back pain buy 1mg doxazosin free shipping, arthritis gastritis gerd symptoms order genuine doxazosin on line, or meningitis gastritis diet india discount doxazosin. Anorectal and tonsillopha ryngeal infection also can occur in prepubertal children and often is asymptomatic gastritis diet àâòî cheap doxazosin american express. Infection of the rectum and pharynx can occur alone or with genito urinary tract infection in either sex. Infection involving other mucous membranes can produce conjunctivitis, pharyngitis, or proctitis. Hematogenous spread from mucosal sites can involve skin and joints (arthritis-dermatitis syndrome) and occurs in up to 3% of untreated people with mucosal gonorrhea. Bacteremia can result in a maculopapular rash with necrosis, teno synovitis, and migratory arthritis. The source of the organ ism is exudate and secretions from infected mucosal surfaces; N gonorrhoeae is commu nicable as long as a person harbors the organism. Transmission results from intimate contact, such as sexual acts, parturition, and rarely, household exposure in prepubertal children. Sexual abuse should be considered strongly when genital, rectal, or pharyngeal colonization or infection are diagnosed in prepubertal children beyond the newborn period. In 2010, a total of 309 341 cases of gonorrhea were reported in the United States, a rate of 99 cases per 100 000 population. N gonorrhoeae still is the second most commonly reported notifable disease in the United States, with Chlamydia trachomatis genital tract infection being the most commonly reported. Reported incidence of infection is highest in females 15 through 24 years of age and in males 20 through 24 years of age. Identifcation of gram-negative intracellular diplococci in these smears can be helpful, particularly if the organism is not recovered in culture. However, because of low sensitivity, a negative result should not be considered suffcient for ruling out infection. Selective media that inhibit normal fora and nonpathogenic Neisseria organisms are used for cultures from nonsterile sites, such as the cervix, vagina, rectum, urethra, and phar ynx. Specimens for N gonorrhoeae culture from mucosal sites should be inoculated imme diately onto appropriate agar, because the organism is extremely sensitive to drying and temperature changes. Caution should be exercised when interpreting the signifcance of isolation of Neisseria organisms, because N gonorrhoeae can be confused with other Neisseria species that colonize the genitourinary tract or pharynx. At least 2 confrmatory bacteriologic tests involving different biochemical principles should be performed by the laboratory. Interpretation of culture of N gonorrhoeae from the pharynx of young children necessitates particular caution because of the high carriage rate of nonpathogenic Neisseria species and the serious impli cations of such a culture result. Use of urine specimens increases feasibility of initial testing and follow-up of populations such as adolescents. These techniques also permit dual testing of urine for C trachomatis and N gonorrhoeae. Culture is the most widely used test for identifying N gonorrhoeae from nongenital sites, and specimens also should be sent for antimicrobial susceptibility testing to aid in man agement should infection persist following initial therapy. Cultures should be performed on genital, rectal, and pharyngeal swab specimens for all patients before antimicrobial treat ment is given. Completion of the series of vaccines for hepatitis B and human papillomavirus should be documented, then offered if not completed and if appropriate for the age group. Because of the high prevalence of penicillin, tetracycline, and quinolone-resistant N gonorrhoeae, an extended-spectrum cephalosporin (eg, ceftriaxone, cefxime) is recom mended as initial therapy for children and adults (see Table 3. Antimicrobial 2 resistance is widespread in many parts of the world, so treatment recommendations may vary depending on where infection was acquired. Ceftriaxone is recommended for gonococcal infections of all sites in children and adults. Cefxime is recommended for uncomplicated gonococcal infections of the vagina, pubertal cervix, urethra, and rectum of a prepubertal child. Cefotaxime also can be used for gonococcal ophthalmia, scalp abscesses, and disseminated gonococcal infection in newborn infants. Completion of the series of vaccines for hepa titis B and human papillomavirus should be documented and then recommended if not completed and if appropriate for the age group. All patients beyond the neonatal period with gonorrhea should be treated presumptively for C trachomatis infection (see Chlamydia trachomatis, p 276). A single dose of ceftriaxone, spectinomycin, or azithromycin is not effec tive treatment for concurrent infection with syphilis (see Syphilis, p 690). Test-of-cure samples are not required in adolescents or adults with uncomplicated gonorrhea who are asymptomatic after being treated with one of the recommended anti microbial regimens. However, because reinfection by a new or untreated partner is not uncommon, clinicians may consider advising sexually active adolescents and adults with gonorrhea to be retested 3 months after treatment. Children treated with ceftriaxone do not require follow-up cultures unless they remain in an at-risk environment, but if treated with other regimens, then follow-up culture is indicated. Patients who have symptoms that persist after treatment or whose symptoms recur shortly after treatment should be reevaluated by culture for N gonorrhoeae, and any gonococci isolated should be tested for antimicrobial susceptibility. In addition to submission of clinical specimens for culture and susceptibility testing, a history of recent travel or sexual activity 1 Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates— United States, 2000–2010. Specifc recommendations for management and antimicrobial therapy are as follows: Neonatal Disease. Infants with clinical evidence of ophthalmia neonatorum, scalp abscess, or disseminated infections attributable to N gonorrhoeae should be hospitalized. The mother and her partner(s) also need appropriate examination and management for N gonorrhoeae. Recommended antimicrobial therapy, including that for ophthalmia neonatorum, is ceftriaxone (25–50 mg/kg, intravenously or intra muscularly, not to exceed 125 mg) given once. Infants with gonococcal ophthalmia should receive eye irrigations with saline solution immediately and at frequent intervals until discharge is eliminated. Topical antimicrobial treatment alone is inadequate and unnecessary when recommended systemic antimicrobial treatment is given. Infants with gonococcal ophthalmia should be hospitalized and evaluated for disseminated infection (sepsis, arthritis, meningitis). Recommended therapy for arthritis and septicemia is ceftriaxone or cefotaxime for 7 days. If meningitis is documented, treatment should be continued for a total of 10 to 14 days. Recommendations for treatment of gonococcal infections, by age and weight, are given in Tables 3. Special Problems in Treatment of Children (Beyond the Neonatal Period) and Adolescents. Patients with uncomplicated infections of the vagina, endocervix, urethra, or anorectum and a history of severe adverse reactions to cephalosporins (anaphylaxis, Stevens-Johnson syndrome, and toxic epidermal necrolysis) should be treated with spectinomycin (40 mg/ kg, maximum 2 g, given intramuscularly as a single dose), if available (spectinomycin cur rently is not available in the United States). Because data are limited regarding alternative regimens for treating gonorrhea among people who have documented severe cephalo sporin allergy, consultation with an expert in infectious diseases is recommended. Azithromycin (2 g, orally) is effective against uncomplicated gonococcal infection and C trachomatis infection, but because of concerns regarding emerging antimicrobial resistance to macrolides, its use should be restricted to limited circumstances. Patients with uncomplicated pharyngeal gonococcal infection should be treated with ceftriaxone (Table 3. Spectinomycin is approximately 50% effective for treatment of pharyngeal gonorrhea, so it should be used only in people with a his tory of severe cephalosporin allergy, and a pharyngeal culture should be obtained 3 to 5 days after treatment to verify eradication; spectinomycin currently is not available in the United States. A single dose of ceftriaxone is not effective treatment for concurrent infec tion with syphilis (see Syphilis, p 690). Hence, broad-spectrum treatment regimens are recommended (see Pelvic Infammatory Disease, p 548). Sexually transmitted organisms, such as N gonorrhoeae or C trachomatis, can cause acute epididymitis in sexually active adolescents and young adults but rarely if ever cause acute epididymitis in prepubertal children. The recommended regimen for sexually transmitted epididymitis is ceftriaxone plus doxycycline (see Table 3. Also approved for pro phylaxis of neonatal ophthalmia are 1% tetracycline ophthalmic ointment and 1% silver nitrate, but these no longer are available in the United States. Prophylaxis may be delayed for as long as 1 hour after birth to facilitate parent-infant bonding. The effcacy of topical prophylaxis in preventing chlamydial ophthalmia is less clear, likely because colonization of the nasopharynx is not prevented.
Diseases
- Leptomeningeal capillary - venous angiomatosis
- Focal agyria pachygyria
- Melanoma, malignant
- Myxoma-spotty pigmentation-endocrine overactivity
- Hemangioma, capillary infantile
- Idiopathic diffuse interstitial fibrosis
- Chromosome 8, monosomy 8p
- Tachycardia
- Syringocystadenoma papilliferum
- Kalam Hafeez syndrome
Antifungal activity of fluid extract and essential oil from anise fruits (Pimpinella anisum L gastritis diet of the stars purchase generic doxazosin line. The fruit essential oil of Pimpinella anisum exerts anticonvulsant effects in mice gastritis surgery discount doxazosin. Effects of the naturally occurring alkenylbenzenes eugenol and trans-anethole on drug-metabolizing enzymes in the rat liver gastritis from alcohol order doxazosin with a mastercard. The effects of fruit essential oil of the Pimpinella anisum on acquisition and expression of morphine induced conditioned place preference in mice gastritis jugo de papa discount doxazosin 1 mg visa. The potential effectiveness of essential oils as a treatment for headlice, Pediculus humanus capitis. Note: Caution is advised as supplies of the fruit of this plant can be adulterated by a poisonous look-alike, Japanese star anise (Illicium anisatum L. Due to potential contamination, this herb should not be administered to small children. Traditional Preparation: A tea (decoction) is prepared from the freshly ground seeds and/or fruits. Traditional Uses: Anis de estrella is prepared as a tea along with other anise-flavored medicinal plants and taken for relief from flatulence, gastrointestinal disorders, headache, indigestion, stomach ache, abdominal pain, upset stomach and upper or lower respiratory tract infections. One remedy for cleansing the intestines (limpiar los intestinos) is made with anis seeds/fruits, star anise (anis de estrella) seeds/fruits and wild privet senna (sen) leaves prepared as a tea. Leaves grow in an alternate pattern and are narrow to elliptic, shiny, leathery and dark green. Fruits are glossy brown seeds inside boat shaped seed pods or follicles, each arranged around a central axis in the shape of a star; each star-shaped fruit typically has 8 points but can be 6-13 points. All parts of this tree are highly aromatic with a pleasant, sweet fragrance (Bailey Hortorium Staff 1976). Distribution: Native to southern China and northern Vietnam, this plant grows in cooler tropical and subtropical areas and is cultivated extensively as a culinary spice and for its essential oil (Bailey Hortorium Staff 1976). No health hazards have been identified in the published literature associated with the appropriate use of Chinese star anise (I. Allergic reactions occur rarely, resulting from long-term, repeated exposure (Gruenwald et al. Poisonous Look-Alike: Anis de estrella (Illicium verum) is easily confused with Japanese star anise (Illicium anisatum L. Highly toxic, Japanese star anise seeds contain spasmogenic sesquiterpene lactones including anisatin, neoanisatin and pseudoanisatin which can cause severe adverse effects. Recent case reports of adverse reactions in infants due to administration of star anise tea have alerted the medical community to the potential adulteration of Chinese star anise with the poisonous Japanese star anise; therefore, it is recommended that star anise tea not be administered to infants or young children due to their particular vulnerability. Symptoms of toxicity from Japanese star anise in infants include vomiting, seizures and unusual irritability (Ize-Ludlow et al. Cases of confirmed adulteration of Chinese star anise with Japanese star anise have been reported in the literature. In one case, the tea was administered to an infant (< 6 months of age) and resulted in symptoms of excessive crying and excitability, hypertonia, nystagmus, spasms or tremors and vomiting (Minodier et al. Several infants presented with acute neurologic and gastrointestinal symptoms that were associated (in a case-controlled study) with consumption of star anise infusion; laboratory tests confirmed that the source of the star anise used was adulterated with other star anise species besides Illicium verum (Garzo Fernandez et al. An epidemic of epileptic, tonic-clonic seizures (16 persons) associated with ingestion of a star anise tea was reported with 63 individuals exhibiting symptoms of nausea and vomiting within 2-4 hours of drinking the infusion. Another incident of a newborn who was administered large amounts of star anise tea resulted in convulsions which required three doses of diazepam to control (Gil Campos et al. Laboratory protocols for analyzing these species have been proposed to detect adulteration and improve quality control. A simpler and quicker method to determine possible adulteration is performed by using gas chromatography and/or fluorescent or scanning electron microscopy to examine distinguishing anatomical features in the epicarp cells of the fruits (Joshi et al. Animal Toxicity Studies: Oral administration of isolated sesquiterpenoids from Chinese star anise (Illicium verum; compounds: veranisatins A, B and C; Okuyama et al. Contraindications: Avoid use in children due to potentially toxic effects from possible contamination with Japanese star anise seeds (Ize-Ludlow et al. Do not use in patients with a history of epilepsy or other convulsive disorders due to case reports of seizures associated with internal use of the tea (Nakamura et al. Due to potential risk of increased bleeding, caution is advised in patients prior to surgery. Anis de 123 estrellas therapeutic properties (concentrated in the essential oil and flavonoids) include bronchial expectorant (affecting the mucous membrane of the respiratory tract) and antispasmodic (affecting the smooth muscle of the gastrointestinal tract; Gruenwald et al. However, the recent development of microbial production of shikimic acid has reduced the need for star anise fruit in the manufacture of this drug (Johansson & Liden 2006, Kramer et al. The fruit contains a high concentration of essential oil, and its most notable constituent is shikimic acid. Other major chemical constituents include: 1,8-cineole, allo-aromadendrene, alpha copaene, alpha-pinene, caryophyllene, essential oil, estragole, feniculin, limonene, linalool, methyl chavicol and trans-anethole (Duke & Beckstrom-Sternberg 1998). Indications and Usage: Chinese star anise seed is approved by the Commission E for the following health conditions: upper or lower respiratory tract infections or colds and gastrointestinal disorders (Blumenthal et al. Recommended daily dosage of the freshly-ground seeds is 3 g ingested, prepared as a tea (0. Laboratory and Preclinical Data: Illicium verum Activity/Effect Preparation Design & Model Results Reference Antiangiogenic Fruits & stem In vitro: human Exhibited moderate to strong Nam et al. Hortus Third: A Concise Dictionary of Plants Cultivated in the United States and Canada. Medicinal Plants used by Latino healers for womens health conditions in New York City. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council and Boston: Integrative Medicine Communications, 685 pp. Chaiyasit D, Choochote W, Rattanachanpichai E, Chaithong U, Chaiwong P, Jitpakdi A, Tippawangkosol P, Riyong D, Pitasawat B. Essential oils as potential adulticides against two populations of Aedes aegypti, the laboratory and natural field strains, in Chiang Mai province, northern Thailand. Garzo Fernandez C, Gomez Pinado P, Barrasa Blanco A, Martinez Arrieta R, Ramirez Fernandez R, Ramon Rosa F, Grupo de Trabajo del Anis Estrellado. Effects of dietary cabbage, Brussels sprouts, Illicium verum, Schizandra chinensis and alfalfa on the benzo[alpha]pyrene metabolic system in mouse liver. Effects of dietary Schizandra chinensis, Brussels sprouts and Illicium verum extracts on carcinogen metabolism systems in mouse liver. Transcriptome analysis of a shikimic acid producing strain of Escherichia coli W3110 grown under carbon and phosphate-limited conditions. Kramer M, Bongaerts J, Bovenberg R, Kremer S, Muller U, Orf S, Wubbolts M, Raeven L. Preventive agents against sepsis and new phenylpropanoid glucosides from the fruits of Illicium verum. Inhibitory effects of Vietnamese medicinal plants on tube-like formation of human umbilical venous cells. Traditional Preparation: A tea is prepared by boiling the leaves or infusing the leaves in hot water. Traditional Uses: Perhaps because the leaves of this plant have a sweet, spicy, anise-like scent, they are sometimes used in a manner similar to anis and may be combined with Chinese star anise and anise to make an herbal mixture prepared as a tea. Availability: Dried plant material is sometime sold at botanicas specializing in medicinal plants from the Caribbean. The trunk is rough and ridged with prominent nodes, branching from the base in a perpendicular pattern. Leaves grow in an alternate pattern on winged leafstalks and are large and heart-shaped with prominent veins. Leaves are thin and papery to the touch which distinguishes it from other Piper species with a similar appearance. Flower spikes are composed of slightly curved inflorescences of miniscule flowers. Distribution: this plant can be found in tropical America and the Caribbean and is widespread, growing along forest edges (Liogier 1990). Active compounds include essential oils, tannins, alkaloids, phenyl alkaloids, phenylpropanoids, phenyloctanoids and flavonoids (Diaz and Gottlieb 1979, Tillequin et al. The following compounds have been isolated from the hexane extract of the dried fruits: 1-(1Z-propenyl)-2,4,6 trimethoxybenzene, 3-farnesyl-4-hydroxybenzoic acid and caryophyllene oxide (de Oliveira Chaves & de Oliveira Santos 2002). The isoquinoline alkaloid (E,E)-N-isobutyl-2,4-octadienamide has also been identified in this plant (de Oliveira Santos & de Oliveira Chaves 1999).
Generic 4 mg doxazosin with mastercard. IBS symptoms and treatment Irritable Bowel Syndrome.
All partners gastritis symptoms livestrong doxazosin 2 mg amex, including provincial and territorial health care regulatory authorities gastritis diet þëìàðò cheap doxazosin 2 mg without a prescription, will be consulted on innovative gastritis diet to heal buy doxazosin online pills, evidence-based approaches to address the needs of patients chronic gastritis symptoms uk order cheapest doxazosin. This Framework outlines key areas where progress is needed, and prioritizes areas of focus for action using a public health approach. An Action Plan is included in Appendix 1, and includes the establishment of a research network on Lyme disease. While these actions will reflect those that can be undertaken by the Government of Canada, all interested parties are invited to identify actions that their respective organizations can take to contribute to progress for patients and the front-line health professionals that care for them. This Framework will be reviewed within five years of its publication on the Canada. Statement for the House Foreign Affairs Committee Africa, Global Health and Human Rights Subcommittees Hearing on Global Challenges in Diagnosing and Managing Lyme Disease – Closing Knowledge Gaps Submitted by the Infectious Diseases Society of America. The Federal Framework on Lyme Disease is intended to guide a way forward in areas where the Government of Canada has a role. The Government of Canada will work with public health, healthcare, patient groups, and other interested parties, and will place a strong emphasis on the prevention of Lyme disease so that the risk posed by Lyme disease to Canadians is minimized. Furthermore, the establishment of a Lyme disease research network will begin to address evidence gaps. Public health actions under the Framework will align with the three pillars of: 1) surveillance; 2) education and awareness; and 3) guidelines and best practices. It aims to provide an overview of the key messages expressed by presenters and participants who attended the conference, the majority being patients who shared their personal experiences (see Figure 1). The key messages and ideas summarized in this report are not intended to indicate a consensus of opinion or agreement across patient groups and the medical and scientific communities on these topics. The opinions and views expressed at this Conference are those of the presenters and participants and do not necessarily reflect the opinions and views of the Government of Canada. Participants included patients, representatives of provincial and federal health ministries, researchers, patient groups, health care professionals or other interested Canadians. The three-day conference included a Public Forum on Day 1 that provided the opportunity for patients, caregivers and health professionals to share their experiences. Gregory Taylor, Chief Public Health Officer for the Public Health Agency of Canada, Mr. Daniel Gregson, Past President of the Association of Medical Microbiology and Infectious Disease Canada. Day 2 of the conference began with opening remarks by the Honourable Jane Philpott, Minister of Health and Green Party leader and Member of Parliament Elizabeth Figure 1: Summary of total attendance May (whose private members Bill C-442 lead to the Act). In breakout and plenary sessions during Days 2 and 3, participants had the opportunity to provide ideas for consideration in the development of the Federal Framework for Lyme Disease. The conference focused on the three areas aligned with the Act: fl Medical Surveillance, including incidence rates and associated economic costs. Gregory Taylor, Chief Public Health Officer, Public Health Agency of Canada, welcomed participants to the Public Forum portion of the conference. He noted that the Public Forum is an opportunity for those most directly affected to share their personal experiences with Lyme disease, and these stories will shape and influence discussions during the conference. He also mentioned that there are unanswered questions about Lyme disease that require further research and analysis, and the stories told will provide valuable insight that will help determine how those questions should be answered. He said that this conference is one step in a much broader process of consultation that is essential for the frameworks development. There have been opportunities to provide views prior to the conference, and as the framework develops there will be additional opportunities to provide feedback. His closing message was that the ultimate goal is to build a framework for action that contributes to a better understanding of Lyme disease so that fewer Canadians suffer from its effects. He noted that it has been 27 years since the first Lyme disease patient group was formed in Canada. He also stressed that policy on Lyme disease in Canada must be a made-in-Canada policy, not an imported policy. He said that the scientific evidence that will be presented during the conference will help guide the federal government in forming policies for Lyme disease in Canada. We need your continuing involvement, and we thank you for sharing your stories with us. Speakers included patients, their families and caregivers and health care professionals. A number of common key messages emerged from the speakers personal experiences: fl Canadas medical system has failed Lyme disease patients. Lyme disease symptoms overlap with those of other complex chronic diseases, such as fibromyalgia, chronic fatigue and depression. She thanked fellow parliamentarian Elizabeth May for her tireless work and leadership in bringing the Federal Framework on Lyme Disease Act forward. The voices of patients, scientists, medical practitioners, policy makers and others will help ensure that the framework is guided by their needs and concerns. We need better surveillance and we need more education and awareness to inform both the public and practitioners about this infectious disease. In cooperation with the provinces and territories, Canadians received information to protect themselves. Health professionals have been told to be vigilant in diagnosing Lyme disease and reporting cases to the local health authorities. In closing, Minister Philpott noted that this conference is an essential and important step in continuing to build on this work. Ultimately, the outcomes of this conference are going to help protect the health and well-being of all Canadians. She also thanked all the parliamentarians who helped drive the Act forward, calling Lyme disease the ultimate non-partisan issue. She encouraged all participants and stakeholders to work together: patients, Health Canada, the Public Health Agency of Canada, provincial and territorial departments of health, medical doctors, research agencies, and the official accrediting bodies for doctors. But, I have faith in the framework development process and am confident that it will remain transparent and inclusive. Jim Wilson, President, Canadian Lyme Disease Foundation, thanked Minister Philpott, Elizabeth May and all others who helped bring Bill C-442 into law. He remarked that the number of Canadians affected by Lyme disease needs to be identified, along with an accounting of the burden of the disease. He said, Canada is a large country and we have at least as many Lyme strains as elsewhere in the world. Wilson emphasized that patients and their experts must be seen as equal partners in all aspects of the framework development process, including guideline writing for diagnostics, treatment, prevention, surveillance and research. Association members evaluate new diagnostic tests to ensure the diagnoses patients receive for all infectious processes are the best available based on the best evidence. Gregson noted that this conference brings together patients, delegates and experts to help the Public Health Agency of Canada develop a Federal Framework on Lyme disease. Treatment fl Antibiotic use: o Need for more clinical trials to support the notion that repeated antibiotic treatment is helpful. Worldwide, there are about 10 different tick species capable of transmitting Lyme disease. For example, information on the prevalence of ticks at a provincial level is misleading and almost meaningless. Collaboration and Information Sharing fl the surveillance system is driven by the collaboration of the provinces/territories and federal government. This highlights the need for ongoing, systematic surveillance efforts in all provinces and territories. Community Involvement fl Community involvement in surveillance should be leveraged: o Community involvement increases awareness of the disease. Dissemination and Use of Surveillance Data fl the limitations of surveillance data need to be recognized: o Identification of high risk/endemic areas gives impression that other areas are risk/tick free. Interim solutions for improved diagnostics and testing are needed while the science advances. Researchers fl Researchers are constrained because their science must be evidence based. There is an abundance of information that should be used to benefit Lyme disease research. For example, in vitro experiments are showing that use of a combination of drugs can be effective. Medical Community fl Doctors are constrained by the current guidelines and, in many cases, lack awareness of the disease.
Pokeweed. Doxazosin.
- Are there safety concerns?
- Arthritis-like pain, tonsillitis, laryngitis, mumps, swelling of the lymph glands, scabies, acne, skin cancers, painful menstruation, tonsillitis, and other conditions.
- What is Pokeweed?
- How does Pokeweed work?
- Dosing considerations for Pokeweed.
Source: http://www.rxlist.com/script/main/art.asp?articlekey=96251